Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | esterase, putative | 0.0035 | 0.0164 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.093 | 0.6486 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0342 | 0.0292 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0035 | 0.0164 | 0.0113 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0164 | 0.0113 |
Mycobacterium ulcerans | hypothetical protein | 0.0035 | 0.0164 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.0051 | 0.0059 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0164 | 0.0151 |
Mycobacterium leprae | Probable lipase LipE | 0.0035 | 0.0164 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0051 | 0.0059 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0208 | 0.0195 |
Mycobacterium leprae | conserved hypothetical protein | 0.0035 | 0.0164 | 0.5 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0223 | 0.1494 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0208 | 0.0157 |
Mycobacterium ulcerans | lipase LipD | 0.0035 | 0.0164 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0164 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.093 | 0.6486 | 0.6481 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0035 | 0.0164 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0132 | 0.8063 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0035 | 0.0164 | 0.0232 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0051 | 0.0038 |
Brugia malayi | hypothetical protein | 0.003 | 0.0132 | 0.0081 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0051 | 0.0038 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0164 | 0.0151 |
Echinococcus multilocularis | serine:threonine protein kinase Chk2 | 0.093 | 0.6486 | 1 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0164 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0035 | 0.0164 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0132 | 0.8063 |
Entamoeba histolytica | protein kinase, putative | 0.093 | 0.6486 | 1 |
Echinococcus multilocularis | calcium:calmodulin dependent protein kinase I | 0.0929 | 0.6483 | 0.9996 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0035 | 0.0164 | 0.0232 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1427 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | beta-lactamase | 0.0035 | 0.0164 | 0.0113 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase I | 0.0929 | 0.6483 | 0.9996 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0342 | 0.0292 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0342 | 0.0292 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0051 | 0.0059 |
Onchocerca volvulus | 0.0035 | 0.0164 | 0.5 | |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.0051 | 0.0059 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0342 | 0.0292 |
Loa Loa (eye worm) | beta-lactamase | 0.0035 | 0.0164 | 0.0113 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0936 | 0.0889 |
Mycobacterium ulcerans | beta-lactamase | 0.0035 | 0.0164 | 0.5 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0132 | 0.8063 |
Onchocerca volvulus | 0.0035 | 0.0164 | 0.5 | |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0164 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0051 | 0.0038 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0164 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.0051 | 0.0038 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0132 | 0.0081 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0164 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0208 | 0.0157 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0936 | 0.0889 |
Toxoplasma gondii | ABC1 family protein | 0.0035 | 0.0164 | 1 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0164 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.0051 | 0.0059 |
Loa Loa (eye worm) | CAMK/CAMKL/CHK1 protein kinase | 0.1427 | 1 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0035 | 0.0164 | 0.0113 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0164 | 0.0113 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0164 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0164 | 0.5 |
Onchocerca volvulus | 0.0035 | 0.0164 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Brugia malayi | hypothetical protein | 0.002 | 0.0056 | 0.0004 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0164 | 1 |
Echinococcus granulosus | serine:threonine protein kinase Chk2 | 0.093 | 0.6486 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0132 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0936 | 0.0889 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0035 | 0.0164 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0164 | 0.0113 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0132 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0132 | 0.8063 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.0119 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.8584 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 9.285 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 75.6863 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.